fbpx

Male, 85 y/o

Patient internal ID: 9598455

ICD-10 code

C61 Malignant Neoplasm of Prostate

Diagnosis (incl metastases/stage) and year

September 2010
Prostate Adenocarcinoma pT3A Nx Mx, Gleason (4+4) = 8, G3, R1. Disease progression in January 2017, Metastasis in L1-L2 Vertebral.

Previous treatment

Surgery (TURP), Chemotherapy (Docetaxel), Hormone Therapy (Goserelin).

Prognosis and survival expectation

The prognosis remains poor, patients with Advanced Prostate cancer have a 5-year survival rate of close to 30%. The median survival is~42 months from diagnosis.

Treatment provided

Autologous DCV (7 doses) over a period of 5 months.

Patient survival/condition and year

The patient had survived for 37 months since the diagnosis. The patient had multiple vertebrae metastasis, leading to severe pain syndrome. The patient did not reach the median survival, therefore no conclusions can be made.

Date of Review

25/01/2024